...
机译:平衡静脉血栓栓塞试验中的风险和益处:双重终点试验设计和分析方法的概念
Department of Biostatistics and Informatics University of Colorado Aurora CO United States;
Department of Medicine Division of Hematology Hofstra North Shore/LIJ School of Medicine Lenox;
Department of Medicine Division of Cardiology Mount Sinai School of Medicine New York NY;
Department of Medicine and Lombardi Comprehensive Cancer Center Georgetown University Medical;
Department of Medicine Division of Hematology and Thromboembolism McMaster University Hamilton;
Université Paris VII-Denis Diderot Paris France;
Department of Medicine Division of Hematology and Thromboembolism McMaster University Hamilton;
Worldwide Clinical Trials Beverly Hills CA United States;
Department of Medicine Division of Cardiology University of Colorado School of Medicine-Anschutz;
Departments of Pediatrics and Medicine Divisions of Hematology Johns Hopkins University School of;
Anticoagulants; Safety; Treatment efficacy; Venous thromboembolism;
机译:在静脉血栓栓塞试验中平衡风险和收益:双变量终点试验设计和分析方法的概念
机译:静脉血栓栓塞的预防:试验结果是否使临床医生和患者能够评估其益处是否合理?特设工作组会议记录
机译:他们的方法很疯狂-应对:预防静脉血栓栓塞:试验结果是否可使临床医生和患者评估其益处是否可证明风险合理?特设工作组会议记录
机译:根据不同的复合疗效终点,Fongaparinux优于烯库中的优越性在烯库血栓栓塞中的一致性
机译:基于贝叶斯决策理论框架的基于活动比较者的利益风险评估在评估新化学实体的临床试验设计特征中的应用。
机译:在静脉血栓栓塞试验中平衡风险和收益
机译:静脉血栓栓塞的预防:试验结果是否可使临床医生和患者评估其益处是否可证明该风险合理?特设工作组会议记录